Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Finding the elusive drinking ‘brake’

Finding the elusive drinking ‘brake’

Finding the elusive drinking ‘brake’
Credit: UC Santa Barbara

It’s a common scene in bars and clubs: messy, falling-down drunk, slurring and incoherent, precariously close to catastrophe … and asking the bartender for another shot.

For the majority of us who imbibe, there is a certain point at which we stop pounding the drinks, and many reasons we do so. Maybe we sense that we’re close to our limit, or we notice we don’t feel as well—physically and emotionally—as we did a couple of glasses ago. And sometimes the sedative effects of the alcohol just take over. But for a certain subset of people, nothing—not the risk of losing control or the threat of nausea and dizziness—is enough to put the brakes on their drinking.

UC Santa Barbara neuroscientist Karen Szumlinski, who investigates binge drinking and the repeated stress of overdrinking on the brain, suggests a neurobiological mechanism might underpin this behavior. She and her team have uncovered a mechanism in a small brain structure called the bed nucleus of the stria terminalis (BNST) that helps sense alcohol’s negative effects and modulates the urge to drink. When it doesn’t function properly, however, we lose the ability to perceive when we’ve had enough—or, perhaps, one too many—and we continue to drink.

“If a little bit of intoxication is making you nervous, the BNST is doing its job,” said Szumlinski, a co-author of a paper that appears in the Journal of Neuroscience.

An adaptive response to limit alcohol consumption

The urge for us to do virtually anything comes from signals that loop in and around our brains in areas that govern our perceptions, emotions and desires. These in turn connect to our motor functions and create behaviors. This process involves a complex set of signaling pathways, involving many neurotransmitters, as well as their associated proteins and receptors. Those examined in this study are specific to an area of the brain highly implicated in the interface between anxiety and motivation—the BNST, which is connected to, among other things, both the amygdala (which modulates fear and anxiety), and the nucleus accumbens (reward, aversion, motivation).

In previous studies, the researchers found that binge drinking elevates several aspects of signaling through the excitatory neurotransmitter glutamate in both the amygdala and the nucleus accumbens. Using a variety of experimental approaches, they also showed that this increased glutamate signaling drove excessive drinking. Along with the BNST, these regions form a subcircuit in the brain known as the extended amygdala.

“So in the amygdala the increased glutamate signaling is going to possibly generate negative emotions, and maybe you start feeling depressed or anxious, and then that will translate to a higher motivation to drink coming out of the nucleus accumbens,” Szumlinski said. Alcoholism—addiction in general—is a shifting target that moves between the motivation toward the “feel-good” effects of the drug and motivation to avoid the unpleasant withdrawal symptoms or to simply feel normal again after the dependency has been established.

The researchers initially presumed that because the BNST is connected to both structures, the function of high glutamate signaling in the BNST is similar to that of the nucleus accumbens and the amygdala. But instead they found it contains a “brake” mechanism, an adaptive response to limit alcohol consumption. And pumping that pedal is a scaffolding protein called Homer2.

As it turns out, Homer2’s effects on the amygdala and nucleus accumbens are opposite to those in the BNST.

“When we manipulated Homer2 (in mouse models)—when we knocked it down in the amygdala or the accumbens—the animals stopped binge drinking,” Szumlinski said. When they reduced the expression of Homer2 in the BNST, however, the animals binge drank more. And according to Szumlinski, a lot more.

“We know that the ability of Homer2 to interact with the glutamate receptors (mGlu5) can be regulated in a number of ways,” she continued. “And so we wanted to know: What other part(s) of the signaling pathway is interacting with Homer2, and how might that be contributing to the brake process in the BNST?”

They found their answer in an enzyme. Extracellular signal-regulated kinase (ERK, for short) is another of the usual suspects in the realm of addictive disorders. In a mouse model that carried a mutation in its mGlu5 receptors resulting in their inability to be activated by ERK, the researchers found that the mutation had an unexpectedly significant impact on alcohol preference and consumption.

“Based on the available biochemical information at the time we started testing the mGlu5 mutant mice, we predicted a minimal impact on any behavior,” Szumlinski said. The receptor still worked, it just wasn’t sensitive to ERK, she explained. “But there was a huge impact on drinking behavior in a direction opposite to what we predicted.” The mutant mice instead exhibited strong preferences for environments in which they experienced the effects of high-dose alcohol (doses that normal mice find aversive) and the mice consumed large amounts of high-dose alcohol under a number of different drinking procedures.

“So it really showed that something’s going on when you drink alcohol,” she said of this brake in the BNST. “You’re activating this enzyme ERK, which would normally phosphorylate the mGlu5 receptor, and help Homer2 bind better. All of this together serves as a brake to reduce or at least curb your alcohol consumption. But if any kink happens in that little bit of signaling there, you lose the brakes. Your brake line has been cut, and now you exhibit uncontrolled drinking behavior.”

Flying in the face of accepted notions

While all that is occurring in brain behaviorally, tampering with the BNST also seems to shut down or interfere with the typical aversive feedback that would normally prompt the drinker to stop—perhaps the nausea, dizziness, lack of control. Interestingly, Szumlinski added, messing with ERK-mGlu5 signaling also makes an animal overtly more drunk: compared to normal mice, the mGlu5 mutants studied lost their motor coordination on low doses of alcohol and they remained asleep longer when administered higher alcohol doses. Typical mice find increased alcohol sensitivity aversive. However, the mGlu5 mutants are falling-over drunk to observers, but they seem to interpret their situation as just fine.

It’s a jump to link the behavior of drunk lab mice and drunk people, noted Szumlinski, but there are connections that can be made in the array of complex brain processes that drive alcoholism.

“How we perceive how drunk we are is going to influence our subsequent drinking,” Szumlinski said. “Although their behavior is telling us they are completely intoxicated, maybe they don’t feel hammered. Or maybe when they’re feeling drunk, they don’t perceive that as a bad thing. Their awareness of their intoxicated state does not line up with their high-dose alcohol preference or their drinking behavior. And so presumably that might have something to do with BNST glutamate function.”

These results fly in the face of the widely accepted notion that one’s sensitivity to alcohol dictates their likelihood of drinking, Szumlinksi said.

“There’s a lot of literature, including lots of human data, that says if you are more sensitive to the intoxicating effects of alcohol, you are less likely to drink,” Szumlinski said. “We see this is in the genetic literature with people who have the various different enzyme mutations. Examples of these sensitivities are demonstrated in, among other reactions, the flushing, headaches or nasal congestion that happens for some people when they consume alcohol.

“This study says you can be incredibly sensitive to the intoxicating effects of alcohol, but that doesn’t necessarily feed back on you the way it should,” she continued. “And, presumably, the ability of that intoxication to signal to your body: ‘Hey, stop drinking,’ is somehow regulated by the BNST. The big questions now are: What is the identity of the neural circuit containing the BNST that allows the brakes to engage and how do ‘bad BNST brakes’ relate to Alcohol Use Disorder in the human condition?”


Modulating stress circuits


More information:
Rianne R. Campbell et al. Increased alcohol-drinking induced by manipulations of mGlu5 phosphorylation within the bed nucleus of the stria terminalis, The Journal of Neuroscience (2019). DOI: 10.1523/JNEUROSCI.1909-18.2018


Provided by
University of California – Santa Barbara

Citation:
Finding the elusive drinking ‘brake’ (2019, February 21)
retrieved 26 March 2019
from https://medicalxpress.com/news/2019-02-elusive.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Tagged with:

About author

Related Articles